CPHI & PMEC Shenzhen is a new, highly positioned premium pharmaceutical trade event. It aims to be the “launchpad for next-generation pharma” and is strategically located in one of China's most open and economically vibrant regions—the Guangdong-Hong Kong-Macao Greater Bay Area—serving as a gateway to the broader Asia-Pacific market.
The event leverages the area's growing biopharmaceutical industry cluster, with a particular emphasis on driving industry transformation and elevation through advancements in new drug research and development.
Though a young event, its growth trajectory is impressive. The first edition in 20254 successfully attracted 421 exhibiting companies and over 10,000 professional visitors.
It comprehensively covers the global pharmaceutical supply chain, from APIs, finished dosage, biotech, contract services, and natural extracts to machinery, packaging, clean technology, and laboratory instruments, with a strong focus on fostering connections in biotech and R&D advancements. Through a series of high-level conferences and targeted business matchmaking, it creates a strategic environment for ambitious pharma companies to forge connections and spark growth.